NITTOSEIKO (5957) FY2026 Q1 Earnings Report

Quick View

Executive Summary

In addition to higher revenue, improved profitability in the Fastener and Industrial Machinery Businesses drove a strong set of results, with operating income increasing +82.5% year on year. Revenue was ¥125.9B (+8.8% YoY), operating income was ¥9.9B (+82.5%), ordinary income was ¥9.6B (+79.9%), and net income (consolidated net income) was ¥6.8B (+144.0%). The operating margin improved by approximately 3.2pt from the same period of the previous year to 7.8%. The significant increase in profit, well above the revenue growth rate, suggests improved profitability in both cost of sales and selling, general and administrative expenses.

Factors Affecting Performance

【Revenue】Revenue was ¥125.9B, up +8.8% year on year. The core Fastener Business, which accounted for 74.5% of the total, grew revenue by +9.4%, while the Industrial Machinery Business, accounting for 12.4%, grew revenue by +19.0%, driving company-wide growth. Meanwhile, the Control Business, accounting for 12.9%, experienced a ▲3.2% decline in revenue, while the Medical Business achieved +120.8% revenue growth despite its small scale.

【Profit and Loss】Operating income was ¥9.9B (+82.5% YoY), representing profit growth substantially above the revenue growth rate. Operating income in the Fastener Business was ¥6.3B (+157.9% YoY; margin 6.7%), while the Industrial Machinery Business recorded ¥2.8B (+59.7%; margin 17.7%), with improved profitability contributing to the increase. In contrast, the Control Business posted ¥1.1B (▲25.5% YoY), and the Medical Business reported an expanded operating loss of ▲¥0.3B. Extraordinary income of ¥0.2B (gain on sale of investment securities) made a modest contribution to the increase in net income, but the primary driver of profit growth was improved profitability at the operating level. Net income increased substantially to ¥6.8B (+144.0% YoY), resulting in overall higher revenue and profit.

Segment Analysis

The Fastener Business reported revenue of ¥93.8B (+9.4% YoY) and operating income of ¥6.3B (+157.9%). Its operating margin improved significantly from approximately 2.9% in the previous year to 6.7%, making it the central contributor to company-wide profit. The Industrial Machinery Business generated revenue of ¥15.6B (+19.0%) and operating income of ¥2.8B (+59.7%), with the highest profitability among the four businesses at a margin of 17.7%, contributing to the improvement in the company-wide margin. The Control Business recorded revenue of ¥16.3B (▲3.2%) and operating income of ¥1.1B (▲25.5%), reflecting declines in both revenue and profit, with its margin falling to 6.7%. The Medical Business increased revenue despite its small scale, recording ¥0.2B in revenue, but its operating loss expanded to ▲¥0.3B.

Key Financial Indicators

【Profitability】The operating margin of 7.8% improved by approximately 3.2pt from the same period of the previous year. Together with a gross margin of 24.4% and an SG&A ratio of 16.6%, this indicates a structural shift in which profit is growing faster than revenue.【Cash Quality】Cash and deposits were ¥101.8B, substantially exceeding short-term borrowings of ¥18.1B, indicating ample short-term liquidity.【Investment Efficiency】ROE remained at 1.7% (quarterly basis), and even on an annualized basis it is below the generally accepted benchmark of 8%, indicating room for improvement in asset and capital efficiency.【Financial Soundness】The equity ratio was high at 73.2%. With total assets of ¥563.5B and limited interest-bearing debt, the financial base is conservative.

Cash Flow Analysis

Although the cash flow statement has not been separately disclosed, changes in the balance sheet indicate that cash and deposits declined slightly to ¥101.8B from ¥104.9B in the previous year. Current assets were ¥346.2B and current liabilities were ¥105.3B, resulting in a current ratio above 300% and ensuring sufficient short-term payment capacity. Inventories were ¥52.2B, remaining at a certain level relative to revenue growth, and future inventory trends could affect working capital efficiency. Total interest-bearing debt, including short-term and long-term debt, remained limited at approximately ¥25.6B. Compared with net assets of ¥412.4B, financial leverage is low, and financing constraints are considered limited.

Quality of Earnings

Against operating income of ¥9.9B, extraordinary income was limited to ¥0.2B (primarily gains on the sale of investment securities), representing a small proportion of net income. The primary driver of profit growth was therefore improved core operating profitability. Ordinary income was ¥0.3B below operating income because non-operating expenses of ¥0.9B, including ¥0.4B in interest expense, exceeded non-operating income of ¥0.6B. The difference between pre-tax income of ¥9.8B and net income of ¥6.8B resulted from income taxes of ¥3.0B and net income attributable to non-controlling interests of ¥0.8B, with no divergence attributable to unusual accounting treatments. Comprehensive income was ¥7.2B, close to net income of ¥6.8B. The impact of other comprehensive income, including foreign currency translation adjustments of +¥0.4B, was limited, indicating relatively stable earnings quality.

Earnings Forecast and Guidance

Progress against the full-year company plan was 24.2% for revenue (¥125.9B/¥520.0B), 26.0% for operating income (¥9.9B/¥38.0B), 25.2% for ordinary income, and 26.3% for net income. In each case, the deviation from the standard quarterly progress rate of 25% was modest. In particular, progress in operating income and net income was slightly ahead of revenue, indicating that the improvement in Q1 profitability is progressing somewhat ahead of plan. The company has not revised either its earnings forecast or dividend forecast.

Shareholder Returns

The full-year dividend forecast is ¥24.00 per share, implying an increase from the previous year's ¥10 (combined interim and year-end dividends). The forecast payout ratio, calculated using the company's forecast net income of ¥23.0B and forecast total dividends based on the average number of shares outstanding during the period, is approximately 38%. Treasury stock of ¥17.7B is recorded, but the company has not disclosed its share repurchase results for the current period; accordingly, the payout ratio is evaluated based solely on dividends. Cash and deposits of ¥101.8B and the low level of interest-bearing debt support the sustainability of dividend payments.

Risk Factors

1. Business concentration risk: The core Fastener Business accounts for 74.5% of revenue, creating a structure in which fluctuations in demand for this business and capital investment trends among major customers could have a significant impact on company-wide performance.

2. Profitability gap by segment: The Control Business experienced a ▲3.2% year-on-year decline in revenue and a ▲25.5% decline in operating income, while the Medical Business also reported an expanded operating loss. Recovery in the profitability of both businesses will be key to the sustained improvement of the company-wide margin.

3. Working capital efficiency: The company holds inventories of ¥52.2B (finished products ¥52.2B, raw materials ¥40.5B, and work-in-process ¥29.1B). Depending on inventory levels and trends in trade receivables, the working capital burden could expand during a period of revenue growth.

Industry Benchmark (For Reference; Compiled by the Company)

Profitability and Returns

The operating margin exceeds the industry median, while the net margin is slightly below the median, suggesting the impact of income attributable to non-controlling interests and other factors.

Growth and Capital Efficiency

The revenue growth rate exceeds the industry median, representing a relatively high pace of revenue growth within the industry.

※Source: Compiled by the Company

Key Takeaways from the Results

1. The operating margin improved to 7.8%, with a substantial increase of approximately 3.2pt from the same period of the previous year. Profit growth substantially above the revenue growth rate was primarily driven by the business mix and improved profitability, indicating an increase in core earnings power.

2. The Industrial Machinery Business had the highest operating margin among the four businesses at 17.7%, while the Fastener Business was the largest core contributor, with an operating income contribution of ¥6.3B. Meanwhile, deteriorating profitability in the Control and Medical Businesses is a point to consider when evaluating the sustainability of the improvement in the company-wide margin.

3. Progress against the full-year plan was approximately 25% for both revenue and profit, in line with the plan, and the company maintained its earnings and dividend forecasts. The financial base is conservative, with an equity ratio of 73.2% and low interest-bearing debt. Future trends in working capital efficiency will be a key area to monitor in assessing improvements in capital efficiency.

Theoretical Share Price (Reference Value)

Sensitivity: ¥997–¥1,055 at ±1% for the cost of equity, and ¥1,022–¥1,028 at ±0.1 for ω.

Notes:

• Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the end of the quarter are used (there is a timing difference relative to the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting professionals as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q1 was a strong start, with revenue growth translating into materially faster operating and attributable-profit growth. Revenue rose 8.8% YoY to ¥12.59bn. Operating income increased 82.5% YoY to ¥0.99bn, and the operating margin expanded to 7.8% from 4.7%, a 317bp improvement. Profit attributable to owners of parent rose 149.4% YoY to ¥0.60bn, producing EPS of ¥16.66. The attributable net margin increased to 4.8% from 2.1%, a 271bp expansion. Gross profit rose 10.4% YoY to ¥3.08bn, slightly ahead of sales growth, lifting the gross margin by roughly 31bp to 24.4%. SG&A expense declined 7.0% YoY to ¥2.09bn despite higher sales, reducing the SG&A-to-sales ratio by about 280bp to 16.6%. This favorable cost leverage was the principal driver of the operating-margin recovery. Fastener was the core business, contributing ¥6.32bn of segment profit, 63.9% of consolidated operating income. The industrial machinery segment also performed well, supported by a 19.0% revenue increase and a 59.7% increase in segment profit. In contrast, the control segment recorded declining sales and lower segment profit, while the medical segment remained loss-making. Ordinary income of ¥0.96bn was 3.1% below operating income because non-operating expenses exceeded non-operating income. A ¥0.23bn gain on sale of investment securities supported pre-tax income, but represented only 3.8% of profit attributable to owners and does not dominate earnings. Q1 progress against full-year guidance is broadly in line with a normal seasonal profile, at 24.2% for revenue and 26.0% for operating income. The key forward issue is whether improved Fastener profitability and lower SG&A intensity can offset the working-capital burden implied by elevated inventory days and a long cash conversion cycle.

Profitability Analysis

The supplied annualized DuPont ROE is 5.9%, decomposed into a 4.8% net profit margin, 0.894x annualized asset turnover, and 1.37x financial leverage. The largest positive change was in profitability rather than leverage: operating margin rose 317bp YoY to 7.8%, while the attributable net margin rose 271bp to 4.8%. Gross margin improved to 24.4% as gross profit grew 10.4%, ahead of the 8.8% sales increase. More importantly, SG&A fell 7.0% YoY, generating substantial operating leverage: SG&A represented 16.6% of sales versus approximately 19.4% in the prior-year quarter. The resulting 82.5% increase in operating income substantially exceeded sales growth. The five-factor decomposition indicates a 0.994 interest burden, confirming that financing costs have limited impact on EBIT-to-pre-tax-income conversion. The tax burden was 0.616, equivalent to a 30.2% effective tax rate, which is within a normal Japanese corporate range. Interest coverage of 24.87x is strong despite interest expense rising to ¥0.40bn. Fastener segment margin expanded to 6.7% from 2.9%, while industrial machinery margin rose to 17.8% from 13.2%, validating that the group-level margin gain was operationally broad-based across its two largest profit contributors. Control segment margin declined to 6.7% from 8.7%, however, and its 25.5% segment-profit decline warrants monitoring. The reported annualized ROE remains below the 8% benchmark despite the Q1 earnings rebound, reflecting a conservative balance sheet and still-moderate net margin rather than excessive financial leverage.

Growth Assessment

Revenue growth of 8.8% was led by the Fastener segment, where sales increased 9.4% YoY to ¥9.38bn, and the industrial machinery segment, where sales rose 19.0% to ¥1.56bn. Fastener accounted for 74.5% of consolidated revenue and is therefore the principal determinant of group sales and earnings momentum. Its segment profit increased 158.0% YoY to ¥0.63bn, substantially outpacing revenue growth. Industrial machinery generated segment profit of ¥0.28bn, up 59.7% YoY, with a segment margin of 17.8%. Control revenue declined 3.2% YoY to ¥1.63bn and segment profit declined 25.5% to ¥0.11bn, indicating uneven demand or profitability across the portfolio. Medical revenue increased to ¥0.25bn from a low base, but its ¥0.30bn segment loss widened from ¥0.24bn. Full-year guidance calls for revenue of ¥52.0bn, up 3.5% YoY, and operating income of ¥3.8bn, up 10.7% YoY. Q1 revenue progress is 24.2% of the full-year target, close to the standard 25% pace. Operating-income progress is 26.0%, 1.0 percentage point ahead of the standard pace, while attributable-profit progress is 26.3%. These progress rates support the current forecast framework, although sustaining Q1-level profit growth would require continued margin expansion beyond the full-year guidance assumptions. The modest contribution from the securities-sale gain means the underlying earnings trend is primarily operating in nature.

Financial Health

The balance sheet is conservative, with total equity of ¥41.24bn representing 73.2% of total assets and total liabilities representing 26.8%. Liquidity is strong: the current ratio is 328.9%, the quick ratio is 279.3%, and working capital is ¥24.09bn. Cash and deposits of ¥10.18bn exceed short-term loans of ¥1.81bn by 5.62x. Interest-bearing debt totals ¥2.56bn, equivalent to 5.9% of capital, and the interest-bearing debt-to-equity ratio is approximately 0.07x. Long-term loans are only ¥0.75bn, while 70.6% of interest-bearing debt is short term. This short-term debt concentration creates a refinancing-risk flag because funding maturities are relatively front-loaded. The practical impact is mitigated by the substantial cash balance, high quick ratio, and strong interest coverage, but the company should preserve liquidity discipline if working capital remains elevated. Accounts payable of ¥3.92bn and electronically recorded obligations of ¥2.17bn provide meaningful operating funding. Goodwill is ¥0.42bn, only 1.0% of equity and 0.7% of total assets, indicating limited balance-sheet dependence on acquired-business valuations. Intangible assets are also modest at 1.9% of assets. Net defined-benefit liability of ¥1.85bn is a material non-debt obligation to monitor, although it is well supported by the group’s equity base.

Notable B/S Changes

Provision for bonuses: +¥0.34bn (+155.5% YoY) to ¥0.56bn - a seasonal or performance-related accrual increase that raised current liabilities. Electronically recorded obligations: -¥1.19bn (-35.5% YoY) to ¥2.17bn - reduced use of electronic supplier-payment obligations increases the importance of monitoring operating working-capital funding. Income taxes payable: -¥0.38bn (-50.9% YoY) to ¥0.37bn - lower unpaid tax obligations supported the decline in current liabilities. Short-term loans: +¥0.10bn (+5.6% YoY) to ¥1.81bn, while long-term loans declined ¥0.21bn (-21.8%) to ¥0.75bn - debt maturities became more concentrated in short-term funding, although cash coverage remains strong.

Cash Flow Quality

Operating cash-flow conversion should be assessed alongside the company’s working-capital profile. Inventory days are 117 days on an annualized basis, exceeding the 90-day warning threshold and indicating that a substantial amount of capital is tied up in stock. The annualized cash conversion cycle is 133 days, above the 120-day warning threshold. These metrics suggest that accounting earnings may take longer to convert into cash, particularly during periods of sales expansion. Finished goods were ¥5.22bn, while raw materials and work in process were ¥4.05bn and ¥2.91bn, respectively, highlighting the manufacturing working-capital intensity across procurement, production, and finished inventory. Inventory days are especially important for a fastener and industrial-equipment manufacturer because slowing end-market demand, changes in customer production plans, or product-mix shifts can create obsolescence and valuation risk. Trade receivables declined to ¥7.45bn from ¥8.06bn YoY, and electronically recorded monetary claims declined to ¥4.04bn from ¥4.41bn, which is favorable for collections. Trade payables increased to ¥3.92bn from ¥3.74bn, while electronically recorded obligations decreased to ¥2.17bn from ¥3.36bn; the net reduction in electronic supplier obligations limits the extent to which payables fund the operating cycle. The balance-sheet trend therefore reinforces the need to monitor inventory normalization and cash conversion as revenue grows. The limited contribution of extraordinary gains to attributable profit is favorable for earnings quality.

Dividend Sustainability

The full-year dividend forecast is ¥24.00 per share, unchanged from the disclosed plan. Against forecast EPS of ¥63.36, the implied dividend payout ratio is 37.9%. This is below the 60% sustainability benchmark and leaves meaningful earnings retention capacity. Q1 EPS of ¥16.66 represents 26.3% of full-year forecast EPS, broadly consistent with the full-year earnings plan. The company’s strong liquidity, low interest-bearing debt relative to equity, and solid interest coverage support dividend capacity. Retained earnings of ¥295.67bn provide a substantial capital base relative to the planned cash dividend. Dividend sustainability nevertheless depends on keeping working capital under control, given the 117-day annualized inventory period and 133-day annualized cash conversion cycle. No change to the dividend plan has been announced.

Risk Assessment

Business risks include Inventory and demand risk: annualized inventory days of 117 exceed the 90-day warning threshold. A slowdown in customer demand or adverse product-mix changes could require inventory markdowns or impair production efficiency., Working-capital risk: the annualized cash conversion cycle of 133 days exceeds the 120-day warning threshold, increasing the capital required to support growth and potentially delaying cash realization from earnings., Segment concentration risk: Fastener generated 74.5% of group revenue and 63.9% of segment operating profit. Its sustained margin recovery is central to consolidated earnings delivery., Control segment risk: sales declined 3.2% YoY and segment profit declined 25.5% YoY, contrasting with the strong Fastener and industrial machinery performance., Medical business risk: the medical segment remained loss-making, with a ¥0.30bn segment loss, and requires progress toward scale and profitability., Manufacturing-cycle risk: exposure to customer production schedules, raw-material costs, supply-chain conditions, quality requirements, and industrial capital-expenditure cycles can affect volumes and margins..

Financial risks include Refinancing risk: 70.6% of interest-bearing debt is short term, above the 40% alert threshold. Cash coverage of 5.62x short-term debt substantially reduces near-term stress, but maturity concentration remains relevant., Interest-cost risk: interest expense rose to ¥0.40bn from ¥0.03bn YoY. Interest coverage remains strong at 24.87x, but further funding-cost increases would reduce ordinary-income conversion., Pension obligation risk: net defined-benefit liability of ¥1.85bn may expose equity and future expense to actuarial and asset-return movements..

Key concerns include The sustainability of the 317bp operating-margin expansion depends on maintaining lower SG&A intensity and the improved Fastener segment margin., Inventory and cash-conversion performance should improve as sales scale; otherwise, incremental growth may consume a disproportionate amount of liquidity., The full-year operating-income forecast assumes a much more moderate 10.7% YoY increase than the Q1 82.5% increase, implying that quarterly profitability may normalize through the year..

Investment Implications

Key takeaways include Q1 operating income increased 82.5% YoY to ¥0.99bn, driven by margin expansion rather than sales growth alone., Operating margin rose 317bp to 7.8%, supported by gross-margin improvement and a 7.0% reduction in SG&A expense., Fastener and industrial machinery drove the recovery, while Control weakened and Medical remained loss-making., Q1 progress of 24.2% for revenue and 26.0% for operating income is consistent with the full-year guidance trajectory., The balance sheet provides substantial resilience, but elevated inventory days and the long cash conversion cycle are the principal operational financial risks..

Metrics to watch include Fastener segment margin and revenue growth, Industrial machinery segment margin sustainability, Control segment sales and profit recovery, Medical segment loss reduction, Annualized inventory days and cash conversion cycle, Short-term debt share and interest expense, Operating-income progress relative to the ¥3.8bn full-year forecast.

Regarding relative positioning, Nitto Seiko combines a conservative capital structure, strong liquidity, and limited goodwill exposure with an improving operating-profit profile. Its annualized 5.9% ROE and 7.8% operating margin are improved but remain below high-return manufacturing benchmarks, while the 117-day inventory period and 133-day cash conversion cycle are less efficient than preferred manufacturing working-capital levels.